Compositions and methods for non-targeted activation of endogenous genes
AssigneeAthersys, Inc.
InventorsJohn J. Harrington, Bruce Sherf, Stephen Rundlett
Life of this patent
Estimating the term…
Loading patent…
AssigneeAthersys, Inc.
InventorsJohn J. Harrington, Bruce Sherf, Stephen Rundlett
Estimating the term…
The present invention is directed generally to activating gene expression or causing over-expression of a gene by recombination methods in situ. The invention also is directed generally to methods for expressing an endogenous gene in a cell at levels higher than those normally found in the cell. In one embodiment of the invention, expression of an endogenous gene is activated or increased following integration into the cell, by non-homologous or illegitimate recombination, of a regulatory sequence that activates expression of the gene. In another embodiment, the expression of the endogenous gene may be further increased by co-integration of one or more amplifiable markers, and selecting for increased copies of the one or more amplifiable markers located on the integrated vector. In another embodiment, the invention is directed to activation of endogenous genes by non-targeted integration of specialized activation vectors, which are provided by the invention, into the genome of a host cell. The invention also provides methods for the identification, activation, isolation, and/or expression of genes undiscoverable by current methods since no target sequence is necessary for integration. The invention also provides methods for isolation of nucleic acid molecules (particularly cDNA molecules) encoding a variety of proteins, including transmembrane proteins, and for isolation of cells expressing such transmembrane proteins which may be heterologous transmembrane proteins. The invention also is directed to isolated genes, gene products, nucleic acid molecules, to compositions comprising such genes, gene products and nucleic acid molecules, and to vectors and host cells comprising such genes and nucleic acid molecules, that may be used in a variety of therapeutic and diagnostic applications. Thus, by the present invention, endogenous genes, including those associated with human disease and development, may be activated and isolated without prior knowledge of the sequence, structure, function, or expression profile of the genes.
A eukaryotic cell in vitro comprising a vector construct, said vector construct comprising in operable linkage:
A eukaryotic cell in vitro comprising a vector construct, said vector construct comprising operable linkage:
A eukaryotic cell in vitro comprising a vector construct, said vector construct comprising in operable linkage:
A method for making a eukaryotic cell containing a vector construct, said method comprising introducing into a eukaryotic cell in vitro a vector construct comprising in operable linkage:
A method for producing an expression product of an endogenous cellular gene or portion thereof comprising:
A eukaryotic cell library comprising a collection of cells in vitro transformed with a vector construct comprising in operable linkage:
A method for producing an expression product of an endogenous cellular gene or portion thereof in a cell comprising:
A method of identifying a protein product over-expressed by an endogenous cellular gene or portion thereof, said method comprising:
A vector construct comprising in operable linkage:
A vector construct comprising in operable linkage:
A vector construct comprising in operable linkage:
A method for activation of an endogenous cellular gene in a cell comprising:
A method for identifying an endogenous cellular gene containing an exon by identifying a cDNA made from an RNA expression product of that gene, said method comprising:
A method for activating expression from an endogenous cellular gene comprising:
A method for expressing a gene or portion thereof, comprising:
Dependencies are inferred from the claim text.